2 Biotech Stocks You'll Regret Not Buying on the Dip
Biotech stocks were among the first group of equities to head southward late last year. The closely watched iShares Biotechnology ETF and SPDR S&P Biotech ETF are up by 2.56% and 7.62%, respectively, since July 1. Which beaten-down biotech stocks might come roaring back in the second half of 2022?